BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25890247)

  • 1. Quantifying biased signaling in GPCRs using BRET-based biosensors.
    Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
    Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
    Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
    Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.
    Sleno R; Devost D; Pétrin D; Zhang A; Bourque K; Shinjo Y; Aoki J; Inoue A; Hébert TE
    J Biol Chem; 2017 Jul; 292(29):12139-12152. PubMed ID: 28584054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II cyclic analogs as tools to investigate AT
    St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
    Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring Recruitment of β-Arrestin to G Protein-Coupled Heterodimers Using Bioluminescence Resonance Energy Transfer.
    Fillion D; Devost D; Hébert TE
    Methods Mol Biol; 2019; 1957():83-91. PubMed ID: 30919348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation.
    Pétigny C; Dumont AA; Giguère H; Collette A; Holleran BJ; Iftinca M; Altier C; Besserer-Offroy É; Auger-Messier M; Leduc R
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
    Li A; Liu S; Huang R; Ahn S; Lefkowitz RJ
    PLoS One; 2023; 18(3):e0283477. PubMed ID: 36961836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing Arrestin Function Using Intramolecular FlAsH-BRET Biosensors.
    Strungs EG; Luttrell LM; Lee MH
    Methods Mol Biol; 2019; 1957():309-322. PubMed ID: 30919362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.
    Cao Y; Namkung Y; Laporte SA
    Methods Mol Biol; 2019; 1957():59-68. PubMed ID: 30919346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRET-based assay to monitor EGFR transactivation by the AT
    O'Brien SL; Johnstone EKM; Devost D; Conroy J; Reichelt ME; Purdue BW; Ayoub MA; Kawai T; Inoue A; Eguchi S; Hébert TE; Pfleger KDG; Thomas WG
    Biochem Pharmacol; 2018 Dec; 158():232-242. PubMed ID: 30347205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
    Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
    Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin F2α and angiotensin II type 1 receptors exhibit differential cognate G protein coupling regulation.
    Sedki D; Cho A; Cao Y; Nikolajev L; Atmuri NDP; Lubell WD; Laporte SA
    J Biol Chem; 2022 Sep; 298(9):102294. PubMed ID: 35872018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing BRET-based conformational biosensors for G protein-coupled receptors.
    Sleno R; Pétrin D; Devost D; Goupil E; Zhang A; Hébert TE
    Methods; 2016 Jan; 92():11-8. PubMed ID: 25962643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
    Espinoza S; Masri B; Salahpour A; Gainetdinov RR
    Methods Mol Biol; 2013; 964():107-22. PubMed ID: 23296781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of β-Arrestin-Mediated G Protein-Coupled Receptor Ubiquitination Using BRET.
    Nagi K; Shenoy SK
    Methods Mol Biol; 2019; 1957():93-104. PubMed ID: 30919349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased agonism of the angiotensin II type 1 receptor.
    Godin CM; Ferguson SS
    Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling.
    Johnstone EK; Pfleger KD
    Methods Mol Biol; 2015; 1335():191-204. PubMed ID: 26260602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.
    Devost D; Sleno R; Pétrin D; Zhang A; Shinjo Y; Okde R; Aoki J; Inoue A; Hébert TE
    J Biol Chem; 2017 Mar; 292(13):5443-5456. PubMed ID: 28213525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioluminescence Resonance Energy Transfer (BRET) to Detect the Interactions Between Kappa Opioid Receptor and Nonvisual Arrestins.
    Bedini A
    Methods Mol Biol; 2021; 2201():45-58. PubMed ID: 32975788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.